618-63-3

Basic information

• Product Name: 3-Chloro-5-nitrophenol
• Synonyms: 3-Chloro-5-nitrophenol
• CAS NO: 618-63-3
• Molecular Formula: C₆H₄ClNO₃
• Molecular Weight: 173.55
• Mol File: 618-63-3.mol
• Article Data: 6

Chemical Properties

• Melting Point: 147 °C
• Boiling Point: 288.4±25.0 °C(Predicted)
• Appearance: /
• Density: 1.554±0.06 g/cm3(Predicted)
• Storage Temp.: Inert atmosphere,Room Temperature
• PKA: 7.38±0.10(Predicted)
• CAS DataBase Reference: 3-Chloro-5-nitrophenol(CAS DataBase Reference)
• NIST Chemistry Reference: 3-Chloro-5-nitrophenol(618-63-3)
• EPA Substance Registry System: 3-Chloro-5-nitrophenol(618-63-3)

Safety Data

• Hazardous Substances Data: 618-63-3(Hazardous Substances Data)

Usage

General Description

3-Chloro-5-nitrophenol is a type of nitrophenol, which are organic compounds that consist of a phenol group and one or more nitro groups. It is a synthetic compound primarily used in the preparation of dyes and pigments, pharmaceuticals, and pesticides. The compound is recognized by its yellow color, and it can form yellow or yellow-orange crystals. Like many chlorinated and nitro aromatic compounds, 3-Chloro-5-nitrophenol is hazardous and poses risks to human health and the environment. It is soluble in water and various organic solvents, and it is stable under normal temperatures and pressures, yet it can react with oxidizing agents.

Upstream product

• 55910-07-1 1-chloro-3-methoxy-5-nitrobenzene 
• 586-10-7 3-methoxy-5-nitroaniline 
• 618-62-2 3,5-dichloro-1-nitrobenzene 
• 121-88-0 5-Nitro-2-aminophenol 
• 618-86-0 1-chloro-3,5-dinitrobenzene 
• 618-87-1 3, 5-dinitroaniline 

Downstream Products

• 883195-40-2 3-amino-5-chlorophenol 
• 885044-43-9 N-(3-chloro-5-hydroxyphenyl)acetamide 
• 4328-17-0 trinitrophloroglucinol 
• 56140-58-0 1,3-diamino-5-hydroxytrinitrobenzene 
• 22612-97-1 Phosphorsaeure-<5-chlor-3-nitro-phenylester> 
• 1058740-28-5 3-chloro-5-nitro-phenyl trifluoromethanesulphonate 
• 55910-07-1 1-chloro-3-methoxy-5-nitrobenzene 
• 1610449-94-9 1-(3-(tert-butyl)-1-(p-tolyl)-1H-pyrazol-5-yl)-3-(4-((2-((3-chloro-5-(2-(2-(2-methoxyethoxy)ethoxy)ethoxy)phenyl)amino)pyrimidin-4-yl)oxy)naphthalen-1-yl)urea 
• 1610450-65-1 3-chloro-5-(2-(2-(2-methoxyethoxy)ethoxy)ethoxy)aniline 
• 1610450-64-0 1-chloro-3-(2-(2-(2-methoxyethoxy)ethoxy)ethoxy)-5-nitrobenzene 
• 1620403-47-5 C₁₇H₁₄ClNO₃ 

Relevant articles and documents

COMPOUNDS, COMPOSITIONS AND METHODS OF USE

Herein, compounds, compositions and methods for modulating inclusion formation and stress granules in cells related to the onset of neurodegenerative diseases, musculoskeletal diseases, cancer, ophthalmological diseases, and viral infections are described.

Substituted benzodiazepine ring compound and preparation method and application thereof

The invention discloses a substituted benzodiazepine ring compound and a preparation method and application thereof and further relates to a pharmaceutical composition and application of the compound. According to the substituted benzodiazepine ring compound, the effect of preventing or treating an immune inflammatory disease or tumor is achieved through activation of a selectively antagonistic or collaboratively excited NOD1/2 signal transduction pathway; the substituted benzodiazepine ring compound has a polypeptidase stability and is not degraded by polypeptidase in the organism.

NEW SUBSTITUTED ARYLSULPHONYLGLYCINES, THE PREPARATION THEREOF AND THE USE THEREOF AS PHARMACEUTICAL COMPOSITIONS

The present invention relates to substituted arylsulphonylglycines of general formula (I) wherein R, X, Y and Z are defined as in claim 1, the tautomers, enantiomers, diastereomers, mixtures thereof and salts thereof, which have valuable pharmacological properties, particularly the suppression of the interaction of glycogen phosphorylase a with the GL subunit of glycogen-associated protein phosphatase 1 (PP1 ), and their use as pharmaceutical compositions.